The prostate apoptosis response-4 (par-4) gene was identified by diffe
rential screening for genes that are upregulated when prostate cancer
cells are induced to undergo apoptosis. The par-4 gene is induced by a
poptotic signals but not by growth-arresting, necrotic, or growth-stim
ulatory signals. The deduced amino acid sequence of par-4 predicts a p
rotein with a leucine zipper domain at its carboxy terminus. We have r
ecently shown that the Par-4 protein binds, via its leucine zipper dom
ain, to the zinc finger domain of Wilms' tumor protein WT1 (R. W. John
stone et al., Mel. Cell. Biol. 16:6945-6956, 1996). In experiments aim
ed at determining the functional role of par-4 in apoptosis, an antise
nse par-ii oligomer abrogated pal-ii expression and activator-driven a
poptosis in rat prostate cancer cell line AT-3, suggesting that par-4
is required for apoptosis in these cells. Consistent with a functional
role for par-4 in apoptosis, ectopic overexpression of par-4 in prost
ate cancer cell line PC-3 and melanoma cell line A375-C6 conferred sup
ersensitivity to apoptotic stimuli. Transfection studies with deletion
mutants of Par-4 revealed that full-length Par-4, but not mutants tha
t lacked the leucine zipper domain of Par-4, conferred enhanced sensit
ivity to apoptotic stimuli. Most importantly, ectopic coexpression of
the leucine zipper domain of Par-4 inhibited the ability of Par-ii to
enhance apoptosis. Finally, ectopic expression of WT1 attenuated apopt
osis, and coexpression of Par-4 but not a leucine zipperless mutant of
Par-ii rescued the cells from the antiapoptotic effect of WT1. These
findings suggest that the leucine zipper domain is required for the Pa
r-4 protein to function in apoptosis.